Mahesh Padval

Prior to joining Relay Therapeutics, Mahesh Padval was vice president of pharmaceutical sciences and product development at Verastem, Inc. There, he was responsible for preclinical development, CMC and clinical pharmacology activities in support of company’s development programs through non-clinical, clinical development and regulatory filings, including the recent approval and commercial launch of COPIKTRA™.

Prior to Verastem, Mahesh held roles of increasing responsibility at Zalicus, Inc., culminating in his role as vice president of preclinical development and formulations. He also held roles at Charles River Discovery and Development Services and Genzyme Transgenics Corporation.

Mahesh holds a Ph.D. and M.S. in industrial pharmacy from Massachusetts College of Pharmacy, and a Bachelor of Pharmacy from the University of Bombay, India.